GH1 and Obesity: A recent meta-analysis of recombinant human GH as therapy for obesity in adults suggests that GH therapy leads to a decrease in visceral adiposity and increase in lean body mass as well as beneficial changes in lipid profile in obese adults, without inducing weight loss [25].